Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.120
-0.050 (-1.20%)
At close: Nov 22, 2024, 4:00 PM
4.320
+0.200 (4.85%)
After-hours: Nov 22, 2024, 4:20 PM EST
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $124.99 million as of November 22, 2024.
Market Cap
124.99M
Enterprise Value
57.77M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $124.99M, a decrease of -64.90%. That is a compound annual growth rate of -81.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 129.80M | -63.55% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 138.24M |
| Black Diamond Therapeutics | 137.50M |
| Seer, Inc. | 135.03M |
| Innate Pharma | 134.83M |
| Inhibikase Therapeutics | 133.04M |
| Cardiff Oncology | 129.37M |
| Candel Therapeutics | 129.25M |
| Zomedica | 128.57M |